AKT1 and lung adenocarcinoma: Disruption of lipid rafts by mβCD also impairs the activation of the PI3K/Akt pathway in human lung adenocarcinoma A549 cells and Jurkat cells (Motoyama et al., 2009) (Figure 4A, left).